The DOI matches its Crossref record; 116 of the 118 references it cites were found in a registry or an index.
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Abstract
Better biomarkers are urgently needed to improve diagnosis, guide molecularly targeted therapy and monitor activity and therapeutic response across a wide spectrum of disease. Proteomics methods based on mass spectrometry hold special promise for the discovery of novel biomarkers that might form the foundation for new clinical blood tests, but to date their contribution to the diagnostic armamentarium has been disappointing. This is due in part to the lack of a coherent pipeline connecting marker discovery with well-established methods for validation. Advances in methods and technology now enable construction of a comprehensive biomarker pipeline from six essential process components: candidate discovery, qualification, verification, research assay optimization, biomarker validation and commercialization. Better understanding of the overall process of biomarker discovery and validation and of the challenges and strategies inherent in each phase should improve experimental study design, in turn increasing the efficiency of biomarker development and facilitating the delivery and deployment of novel clinical tests.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, the MS detection of low-abundance proteins remains an unsolved challenge due to high dynamic range of the human proteome8–10.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [9]
In the citing paper
“Front-end protein enrichment strategies are therefore required to specifically capture and enrich low-abundance proteins from the complex biological milieu prior to MS analysis9,11.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [9]
In the citing paper
“In particular, the human blood proteome, a circulating representation of all pathophysiological processes, is immensely complex and the huge dynamic range of the blood proteome (1012) dominated by the presence of numerous highly abundant proteins, such as human serum albumin (HSA), makes the detection of low-abundance proteins extremely difficult9,10.”
From Nanoproteomics enables proteoform-resolved analysis of low-abundance proteins in human serum (2020) · cites this paper as [9]
In the citing paper
“additional sources of uncertainty may arise from processes such as protein quantification in bottom-up proteomics (Rifai et al., 2006; Plubell et al., 2022) as measurements are made at the peptide level and isoforms can be difficult to identify (Forshed et al., 2011; Webb-Robertson et al., 2014).”
From Missing data in multi-omics integration: Recent advances through artificial intelligence (2023) · cites this paper as Rifai et al., 2006
Citations
Cites
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Beckett, A. H., Rowland, M., & TURNER, P. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91037-8 · Cited by 16,917
Practical Statistics for Medical Research.
Walter, S., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,666
Mass spectrometry-based proteomics
Aebersold, R., & Mann, M. (2003) · Nature · doi:10.1038/nature01511 · Cited by 6,955
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine
ZWEIG, M. H., & Campbell, G. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.4.561 · Cited by 6,595
Practical Statistics for Medical Research.
Bartko, J. J., & Altman, D. G. (1992) · Journal of the American Statistical Association · doi:10.2307/2290246 · Cited by 4,834
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101
Research works printed but not linked: 2
- Entertainment Industry Foundation, Women's Cancer Research Fund Breast Cancer Biomarker Discovery Project. http://www.eifoundation.org/national/wcrf/press/article2005-10-04.html .
- International Standards Organization, I.O.F.S. Accuracy (Trueness and Precision) of Measurement Methods and Results (ISO 5725)-Part 1: General Principles and Definitions (ISO, Geneva, 1994).
Cited by
Sorted by citations
Items 401–500 of 1,000
Quiescin Sulfhydryl Oxidase 1 (QSOX1) Secreted by Lung Cancer Cells Promotes Cancer Metastasis
Sung, H.-J., Ahn, J., Yoon, Y.-H., Na, S.-S., Choi, Y. J., Kim, Y., Lee, S., Lee, E., Cho, S., & Cho, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103213 · Cited by 59
Sun, Y., Rong, X., Lu, W., Peng, Y., Jiang, L., Xu, S., Wang, L., & Wang, X. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142805 · Cited by 58
The first decade of MALDI protein profiling: A lesson in translational biomarker research
Albrethsen, J. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.02.027 · Cited by 56
Advances in Proteomic Technologies and Its Contribution to the Field of Cancer
Mesri, M. (2014) · Advances in Medicine · doi:10.1155/2014/238045 · Cited by 61
Beer, L. A., Tang, H., Sriswasdi, S., Barnhart, K. T., & Speicher, D. W. (2010) · Journal of Proteome Research · doi:10.1021/pr1008866 · Cited by 58
Serum biomarkers for Alzheimer's disease: Proteomic discovery
German, D. C., Gurnani, P., Nandi, A., Garner, H. R., Fisher, W. G., Diaz-Arrastia, R. R., O’Suilleabhain, P. E., & Rosenblatt, K. P. (2007) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2007.05.009 · Cited by 57
Wang, B., Zhao, M., Mehdi, M., Wang, G., Gao, P., & Zhang, K. (2019) · Materials Chemistry Frontiers · doi:10.1039/c9qm00165d · Cited by 58
Josephs, R. D., Martos, G., Li, M., Wu, L., Melanson, J. E., Quaglia, M., Beltrão, P. J., Prevoo-Franzsen, D., Bœuf, A., Delatour, V., et al. (2019) · Metrologia · doi:10.1088/1681-7575/ab27e5 · Cited by 58
Cellular and Molecular Evidence of Multiple Sclerosis Diagnosis and Treatment Challenges
Khan, Z., Gupta, G. D., & Mehan, S. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134274 · Cited by 59
Biological and methodical challenges of blood-based proteomics in the field of neurological research
Lista, S., Faltraco, F., & Hampel, H. J. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.06.006 · Cited by 58
Schoenherr, R. M., Zhao, L., Whiteaker, J. R., Feng, L.-C., Li, L., Liu, L., Liu, X., & Paulovich, A. G. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.11.017 · Cited by 57
Nice, E. C., Rothacker, J., Weinstock, J., Lim, L., & Catimel, B. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.06.015 · Cited by 57
Guergova-Kuras, M., Kurucz, I., Hempel, W. M., Tardieu, N., Kádas, J., Malderez‐Bloes, C., Jullien, A., Kieffer, Y., Hincapie, M., Guttman, A., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010298 · Cited by 58
Jelonek, K., Pietrowska, M., & Widłak, P. (2017) · International Journal of Radiation Biology · doi:10.1080/09553002.2017.1304590 · Cited by 57
Diagnostic microRNA markers to screen for sporadic human colon cancer in blood.
Ahmed, F., Amed, N. C., Vos, P. W., Bonnerup, C., Atkins, J. N., Casey, M., Nuovo, G. J., Naziri, W., Wiley, J. E., & Allison, R. R. (2012) · PubMed · Cited by 56
Suh, E. J., Kabir, M. H., Kang, U., Lee, J. W., Yu, J., Noh, D., & Lee, C. (2012) · Experimental & Molecular Medicine · doi:10.3858/emm.2012.44.1.003 · Cited by 60
Quantitative proteomics and biomarker discovery in human cancer
Zhao, Y., Lee, W. P., & Xiao, G. G. (2009) · Expert Review of Proteomics · doi:10.1586/epr.09.8 · Cited by 56
A tuberculosis biomarker database: the key to novel TB diagnostics
Yerlikaya, S., Broger, T., MacLean, E. L.-H., Pai, M., & Denkinger, C. M. (2017) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2017.01.025 · Cited by 59
Niwa, Y., Yamada, S., Sonohara, F., Kurimoto, K., Hayashi, M., Tashiro, M., Iwata, N., Kanda, M., Tanaka, C., Kobayashi, D., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-018-1762-6 · Cited by 55
Electrochemical Molecule Trap-Based Sensing of Low-Abundance Enzymes in One Living Cell
Pan, R., Wang, D., Liu, K., Chen, H., & Jiang, D. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c06962 · Cited by 56
LC-MS for protein characterization: current capabilities and future trends
Chen, G., & Pramanik, B. N. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.3.435 · Cited by 55
Quality Improvement in Laboratory Medicine: Extra-Analytical Issues
Lippi, G., Fostini, R., & Guidi, G. C. (2008) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2007.12.007 · Cited by 55
Chen, J., Xi, J., Tian, Y., Bova, G. S., & Zhang, H. (2013) · PROTEOMICS · doi:10.1002/pmic.201200541 · Cited by 55
Qian, W., Liu, T., Petyuk, V., Gritsenko, M. A., Petritis, B. O., Polpitiya, A. D., Kaushal, A., Xiao, W., Finnerty, C. C., Jeschke, M. G., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr800467r · Cited by 55
Rehiman, S. H., Lim, S. M., Neoh, C. F., Majeed, A. B. A., Chin, A., Tan, M. P., Kamaruzzaman, S. B., & Ramasamy, K. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101066 · Cited by 54
DiBattista, A., McIntosh, N., Lamoureux, M., Al-Dirbashi, O. Y., Chakraborty, P. K., & Britz‐McKibbin, P. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01727 · Cited by 54
Han, B., & Higgs, R. E. (2008) · Briefings in Functional Genomics and Proteomics · doi:10.1093/bfgp/eln032 · Cited by 54
Boja, E. S., Fehniger, T. E., Baker, M. S., Marko‐Varga, G., & Rodriguez, H. (2014) · Journal of Proteome Research · doi:10.1021/pr500753r · Cited by 53
Pernemalm, M., Petris, L. D., Eriksson, H., Brandén, E., Koyi, H., Kanter, L., Lewensohn, R., & Lehtiö, J. (2009) · PROTEOMICS · doi:10.1002/pmic.200800814 · Cited by 54
Tanca, A., Pagnozzi, D., Burrai, G. P., Polinas, M., Uzzau, S., Antuofermo, E., & Addis, M. F. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.09.033 · Cited by 55
Amacher, D. E., Schomaker, S., & Aubrecht, J. (2013) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-013-0049-0 · Cited by 54
Großerueschkamp, F., Bracht, T., Diehl, H. C., Küpper, C., Ahrens, M., Kallenbach‐Thieltges, A., Mosig, A., Eisenacher, M., Marcus, K., Behrens, T., et al. (2017) · Scientific Reports · doi:10.1038/srep44829 · Cited by 54
Biomarker Discovery in Animal Health and Disease: The Application of Post-Genomic Technologies
Moore, R. E., Kirwan, J., Doherty, M. K., & Whitfield, P. D. (2007) · Biomarker Insights · doi:10.1177/117727190700200040 · Cited by 60
Banks, R. E. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.097667 · Cited by 54
Proteomics in the pharmaceutical and biotechnology industry: a look to the next decade
Lill, J. R., Mathews, W. R., Rose, C. M., & Schirle, M. (2021) · Expert Review of Proteomics · doi:10.1080/14789450.2021.1962300 · Cited by 57
Optimizing Performance of Glycopeptide Capture for Plasma Proteomics
Berven, F. S., Ahmad, R., Clauser, K. R., & Carr, S. A. (2010) · Journal of Proteome Research · doi:10.1021/pr900845m · Cited by 53
Self-citationDas, C., Zhang, J., Denslow, N. D., & Fan, Z. H. (2007) · Lab on a Chip · doi:10.1039/b712794d · Cited by 53
Proteomic urinary biomarker approach in renal disease: from discovery to implementation
Schanstra, J. P., & Mischak, H. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2790-y · Cited by 53
Hossain, M., Kaleta, D. T., Robinson, E. W., Liu, T., Zhao, R., Page, J. S., Kelly, R., Moore, R. J., Tang, K., Camp, D., et al. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m000062-mcp201 · Cited by 53
Systematic antibody and antigen-based proteomic profiling with microarrays
Ayoglu, B., Månberg, A., Neiman, M., Igel, U., Uhlén, M., Schwenk, J. M., & Nilsson, P. (2011) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.10.110 · Cited by 56
Functional proteomics outlines the complexity of breast cancer molecular subtypes
Gámez‐Pozo, A., Trilla‐Fuertes, L., Berges‐Soria, J., Selevsek, N., López‐Vacas, R., Díaz‐Almirón, M., Nanni, P., Arevalillo, J. M., Navarro, H., Grossmann, J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10493-w · Cited by 53
Shao, B., & Heinecke, J. W. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1402680 · Cited by 55
Cao, Y., Xia, J., Li, L., Zeng, Y., Zhao, J. T., & Li, G. (2024) · JACS Au · doi:10.1021/jacsau.4c00989 · Cited by 54
Biomarkers in drug discovery and development
Bakhtiar, R. (2007) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2007.10.002 · Cited by 50
Ramachandran, S., Venugopal, A., Sathisha, K., Girijadevi, R., Charles, S., Divya, G., Chandran, N. S., Mullassari, A., Pillai, M. R., & Kartha, C. S. (2012) · PROTEOMICS · doi:10.1002/pmic.201100586 · Cited by 52
Kirk, J. T., Brault, N. D., Baehr-Jones, T. W., Hochberg, M. J., Jiang, S., & Ratner, D. M. (2012) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2012.10.079 · Cited by 52
Detection of stably expressed piRNAs in human blood.
Yang, X. F., Cheng, Y., Lü, Q., Wei, J., Yang, H., & Gu, M. (2015) · Europe PMC (PubMed Central) · Cited by 52
Shinchi, H., Wakao, M., Nagata, N., Sakamoto, M., Mochizuki, E., Uematsu, T., Kuwabata, S., & Suda, Y. (2014) · Bioconjugate Chemistry · doi:10.1021/bc400425w · Cited by 53
Citric Acid Metabolism in Resistant Hypertension
Martin‐Lorenzo, M., Martínez, P. J., Martin, M. B., Ruiz‐Hurtado, G., Prado, J. C., Segura, J., de la Cuesta, F., Barderas, M. G., Vivanco, F., Ruilope, L. M., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09819 · Cited by 51
In vitro toxicity model: Upgrades to bridge the gap between preclinical and clinical research
Madorran, E., Stožer, A., Bevc, S., & Maver, U. (2019) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2019.4378 · Cited by 51
Production and Use of Stable Isotope-Labeled Proteins for Absolute Quantitative Proteomics
Lebert, D., Dupuis, A., Garin, J., Bruley, C., & Brun, V. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-148-2_7 · Cited by 51
Wouters, B., Davydova, E., Wouters, S., Vivó‐Truyols, G., Schoenmakers, P. J., & Eeltink, S. (2015) · Lab on a Chip · doi:10.1039/c5lc01169h · Cited by 51
Bakry, R. S., Rainer, M., Huck, C. W., & Bonn, G. K. (2011) · Analytica Chimica Acta · doi:10.1016/j.aca.2011.01.044 · Cited by 51
Dayon, L., Galindo, A. N., Corthésy, J., Cominetti, O., & Kussmann, M. (2014) · Journal of Proteome Research · doi:10.1021/pr500635f · Cited by 51
Tang, H.-Y., Beer, L. A., Chang-Wong, T., Hammond, R., Gimotty, P., Coukos, G., & Speicher, D. (2011) · Journal of Proteome Research · doi:10.1021/pr200603h · Cited by 55
Raphael, I., Webb, J., Stüve, O., Haskins, W. E., & Forsthuber, T. G. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2015.991315 · Cited by 51
Biomarkers for rheumatoid arthritis: Making it personal
Lindström, T. M., & Robinson, W. H. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2010.493406 · Cited by 51
Gagaoua, M., Bonnet, M., & Picard, B. B. (2020) · Foods · doi:10.3390/foods9091180 · Cited by 51
Fijneman, R. J. A., de Wit, M., Pourghiasian, M., Piersma, S. R., Pham, T. V., Warmoes, M. O., Lavaei, M., Piso, C., Smit, F., Diemen, P. M. D., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1937 · Cited by 51
Proteomics Analysis of Tears and Saliva From Sjogren’s Syndrome Patients
Das, N., Menon, N. G., de Almeida, L. G. N., Woods, P. S., Heynen, M., Jay, G. D., Caffery, B. E., Jones, L., Krawetz, R. J., Schmidt, T. A., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.787193 · Cited by 54
LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma
Sato, S., Gillette, M. A., de Santiago, P. R., Kuhn, E. W., Burgess, M. W., Doucette, K., Feng, Y., Mendez‐Dorantes, C., Ippoliti, P. J., Hobday, S. B., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-28840-5 · Cited by 50
Self-citationLabel-free mass spectrometry-based proteomics for biomarker discovery and validation
Pham, T. V., Piersma, S. R., Oudgenoeg, G., & Jiménez, C. R. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.31 · Cited by 52
Biomarkers in Alzheimer’s Disease Analysis by Mass Spectrometry-Based Proteomics
Liu, Y., Qing, H., & Deng, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15057865 · Cited by 51
Multiplexed Detection of Cytokines Based on Dual Bar-Code Strategy and Single-Molecule Counting
Li, W., Jiang, W., Dai, S., & Wang, L. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.5b03043 · Cited by 50
Current application of proteomics in biomarker discovery for inflammatory bowel disease
Chan, P. P. (2016) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v7.i1.27 · Cited by 51
Cuartero, M., Ballus, J., Sabater‐Riera, J., Pérez, X. L., Nín, N., Ordóñez‐Llanos, J., & Betbese, A. J. (2017) · Annals of Intensive Care · doi:10.1186/s13613-017-0317-y · Cited by 50
Tideman, L. E. M., Migas, L. G., Djambazova, K. V., Patterson, N. H., Caprioli, R. M., Spraggins, J. M., & de Plas, R. V. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.338522 · Cited by 50
Cao, P., Tong, L., Hou, Y., Zhao, G., Guérin, G., Winnik, M. A., & Nitz, M. (2012) · Langmuir · doi:10.1021/la302690h · Cited by 50
Liu, J., Cui, D., Jiang, Y., Li, Y., Liu, Z., Tao, L., Zhao, Q. S., & Diao, A. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.10.245 · Cited by 49
Single-molecule immunoassay technology: Recent advances
Wu, Y., Fu, Y., Guo, J., & Guo, J. (2023) · Talanta · doi:10.1016/j.talanta.2023.124903 · Cited by 51
The current status of clinical proteomics and the use of MRM and MRM3for biomarker validation
Lemoine, J., Fortin, T., Salvador, A., Jaffuel, A., Charrier, J., & Choquet‐Kastylevsky, G. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.32 · Cited by 49
Two‐dimensional protein separation in microfluidic devices
Chen, H., & Fan, Z. H. (2009) · Electrophoresis · doi:10.1002/elps.200800566 · Cited by 49
Berna, M. J., & Ackermann, B. L. (2009) · Analytical Chemistry · doi:10.1021/ac9002744 · Cited by 49
Peek a peak: a glance at statistics for quantitative label-free proteomics
Podwojski, K., Eisenacher, M., Kohl, M., Turewicz, M., Meyer, H. E., Rahnenführer, J., & Stephan, C. (2010) · Expert Review of Proteomics · doi:10.1586/epr.09.107 · Cited by 49
Guingab-Cagmat, J. D., Cagmat, E. B., Hayes, R. L., & Anagli, J. Y. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00061 · Cited by 49
Boja, E. S., & Rodriguez, H. (2011) · Annals of Laboratory Medicine · doi:10.3343/kjlm.2011.31.2.61 · Cited by 56
Kaji, H., Ocho, M., Togayachi, A., Kuno, A., Sogabe, M., Ohkura, T., Nozaki, H., Angata, T., Chiba, Y., Ozaki, H., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr301217b · Cited by 49
Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel
Park, J., Choi, Y., Namkung, J., Yi, S. G., Kim, H., Yu, J., Kim, Y., Kwon, W., Kwon, W., Oh, D., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21861 · Cited by 47
A Data Mining Metabolomics Exploration of Glaucoma
Nzoughet, J. K., Guehlouz, K., Leruez, S., Gohier, P., Bocca, C., Muller, J., Blanchet, O., Bonneau, D., Simard, G., Miléa, D., et al. (2020) · Metabolites · doi:10.3390/metabo10020049 · Cited by 49
Machine Learning Approaches for Biomarker Discovery Using Gene Expression Data
Zhang, X., Jonassen, I., & Goksøyr, A. (2021) · Exon Publications eBooks · doi:10.36255/exonpublications.bioinformatics.2021.ch4 · Cited by 50
Zhou, C., Pan, D., Cao, J., & Zhou, G. (2021) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12779 · Cited by 48
Nanopore single-molecule analysis of biomarkers: Providing possible clues to disease diagnosis
Chen, X., Zhou, S., Wang, Y., Zheng, L., Guan, S., Wang, D., Wang, L., & Guan, X. (2023) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2023.117060 · Cited by 48
Chen, J.-Q., Wakefield, L. M., & Goldstein, D. J. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0537-6 · Cited by 48
Phosphoproteomics for the discovery of kinases as cancer biomarkers and drug targets
Yu, L., Issaq, H. J., & Veenstra, T. D. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700102 · Cited by 47
Remily-Wood, E. R., Liu, R. Z., Xiang, Y., Chen, Y., Thomas, C. E., Rajyaguru, N., Kaufman, L. M., Ochoa, J. E., Hazlehurst, L., Pinilla-Ibarz, J. A., et al. (2011) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201000115 · Cited by 48
Drake, P. M., Schilling, B., Niles, R. K., Prakobphol, A., Li, B., Jung, K.-Y., Cho, W., Braten, M. N., Inerowicz, H. D., Williams, K., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr201206w · Cited by 50
Kennedy, J. J., Whiteaker, J. R., Schoenherr, R. M., Yan, P., Allison, K. H., Shipley, M., Lerch, M. L., Hoofnagle, A. N., Baird, G. S., & Paulovich, A. G. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00245 · Cited by 48
Whole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins
Xia, L., Schrump, D. S., & Gildersleeve, J. C. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.10.012 · Cited by 48
Large, T. Y. S. L., Meijer, L. L., Paleckytė, R., Boyd, L. N. C., Kok, B., Wurdinger, T. D., Schelfhorst, T., Piersma, S. R., Pham, T. V., van Grieken, N. C. T., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2019-0680 · Cited by 48
Cerciello, F., Choi, M., Nicastri, A., Bausch‐Fluck, D., Ziegler, A., Olga Vitek, A., Felley‐Bosco, E., Stahel, R. A., Aebersold, R. H., & Wollscheid, B. (2013) · Clinical Proteomics · doi:10.1186/1559-0275-10-16 · Cited by 47
Magro‐Checa, C., Steup‐Beekman, G. M., Huizinga, T. W. J., van Buchem, M. A., & Ronen, I. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00340 · Cited by 48
Proteomic analysis of serum, plasma, and lymph for the identification of biomarkers
Meng, Z., & Veenstra, T. D. (2007) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200700243 · Cited by 48
Advances in single‐molecule fluorescent nanosensors
Liu, M., Qiu, J., Ma, F., & Zhang, C. (2021) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1716 · Cited by 48
Enriching extracellular vesicles for mass spectrometry
Burton, J. B., Carruthers, N. J., & Stemmer, P. M. (2021) · Mass Spectrometry Reviews · doi:10.1002/mas.21738 · Cited by 47
Combined Blood/Tissue Analysis for Cancer Biomarker Discovery: Application to Renal Cell Carcinoma
Johann, D. J., Wei, B., Prieto, D. A., Chan, K. C., Ye, X., Valera, V., Simpson, R. M., Rudnick, P. A., Xiao, Z., Issaq, H. J., et al. (2010) · Analytical Chemistry · doi:10.1021/ac902204k · Cited by 46
Colorectal cancer proteomics, molecular characterization and biomarker discovery
Barderas, R., Babel, I., & Casal, J. I. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900131 · Cited by 46
Dayon, L., Turck, N., Kienle, S., Schulz‐Knappe, P., Hochstrasser, D. F., Scherl, A., & Sanchez, J. (2010) · Analytical Chemistry · doi:10.1021/ac901854k · Cited by 46
Applying selected reaction monitoring to targeted proteomics
Calvo, E., Camafeita, E., Fernández‐Gutiérrez, B., & López, J. A. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.11 · Cited by 46
Targeted proteomics: a bridge between discovery and validation
Harlan, R., & Zhang, H. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.976558 · Cited by 46
N-Glycoprotein Analysis Discovers New Up-Regulated Glycoproteins in Colorectal Cancer Tissue
Nicastri, A., Gaspari, M., Sacco, R., Elia, L., Gabriele, C., Romano, R., Rizzuto, A., & Cuda, G. (2014) · Journal of Proteome Research · doi:10.1021/pr500647y · Cited by 45
Metadata
- Authors
- Rifai, N., Gillette, M. A., & Carr, S. A.
- Affiliations
- Boston Children's Hospital (US)
- Broad Institute (US)
- Corresponding author
- Carr, Steven A
- Venue
- Nature Biotechnology
- Published
- 2006-08
- Volume
- 24
- Issue
- 8
- Pages
- 971-983
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2094229819
- Cited by
- 1,867
- References
- 118
- Citations by year
- 2026: 56 · 2025: 70 · 2024: 75 · 2023: 66 · 2022: 69 · 2021: 85 · 2020: 74 · 2019: 88 · 2018: 91 · 2017: 96 · 2016: 99 · 2015: 130 · 2014: 131 · 2013: 116 · 2012: 138
- FWCI
- 7.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Keywords
- protein biomarkers, biomarker discovery, biomarker validation, mass spectrometry-based proteomics, diagnostic biomarkers, biomarker qualification, research design
- MeSH terms
- Animals, Blood Chemical Analysis, Blood Proteins, Humans, Peptide Mapping, Sensitivity and Specificity, Mass Spectrometry, Biomarkers, Protein Array Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
